Logo

American Heart Association

  16
  0


Final ID: MP2005

Sympathetic Denervation as a Substrate for Persistent Atrial Fibrillation Assessed Using 11C-Hydroxyephedrine PET Imaging

Abstract Body (Do not enter title and authors here): Background:
Atrial fibrillation (AF) is the most common arrhythmia, associated with increased risks of stroke, heart failure, and mortality. Structural and autonomic remodeling contribute to its pathophysiology, with evidence suggesting that sympathetic denervation may promote a pro-arrhythmic substrate. 11C-Hydroxyephedrine (HED) PET enables noninvasive assessment of cardiac sympathetic innervation in AF.

Objective:
To evaluate cardiac sympathetic innervation using HED PET imaging in healthy controls vs. patients with persistent AF, and its relationship to catheter ablation (CA) outcomes.

Methods:
This prospective study enrolled patients with symptomatic persistent AF accepted for clinically indicated CA. Patients were recruited between 2016–2018 at a tertiary center. All underwent HED hybrid PET/CT imaging prior to CA aimed at pulmonary vein isolation. Clinical endpoint was freedom from AF recurrence >30 seconds. Patients had 14-day Holter monitoring at 3, 6, and 12 months, and as needed for symptoms. Image analysis was independently performed by two readers using HERMIA software. Regions of interest were drawn on transaxial, sagittal, and coronal views to capture the left atrial (LA) myocardium and blood pool activity. Minimum, maximum, and range (max–min) of standardized uptake value (SUV) and tissue-to-blood ratio (TBR) in the LA were recorded. Group comparisons used Mann–Whitney U and Kruskal–Wallis tests.

Results:
Thirty-six patients with AF and 7 healthy controls were included (9 females; 61±9 years old). In the AF group (mean LA size 45±8 mm), 26 remained AF-free and 10 had recurrence. Mean AF-free duration was 23±7 months (AF-free) vs. 6±2 months (AF-recur). Mean LA TBR minimum was 0.92±0.15 (controls), 0.66±0.22 (AF-free), and 0.67±0.25 (AF-recur) (p=0.017; Fig. 1). Compared to controls, TBR minimum was lower in AF-free (p=0.007), AF-recur (p=0.022), and all AF patients (p=0.005). TBR range was 1.86±0.28 (controls), 2.88±0.97 (AF-free), and 0.99±1.24 (AF-recur) (p=0.013; Fig. 2); it was elevated in AF-free (p=0.002) and all AF (p=0.003) but did not meet statistical significance for AF-recur (p=0.070).

Conclusion:
Patients with persistent AF exhibit marked sympathetic denervation (low TBR minimum) and regional heterogeneity (high TBR range) on HED PET, suggestive of autonomic imbalance and atrial vulnerability. These patterns may contribute to AF recurrence and warrant further study to assess their role in ablation outcomes.
  • Dai, Yuchen  ( University of Toronto , Toronto , Ontario , Canada )
  • Wells, George  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Beanlands, Rob  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Birnie, David  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Dekemp, Robert  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Nery, Pablo  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Tavoosi, Anahita  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Nair, Girish  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Redpath, Calum  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Golian, Mehrdad  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Thornhill, Rebecca  ( The Ottawa Hospital , Ottawa , Ontario , Canada )
  • Pena-fernandez, Elena  ( The Ottawa Hospital , Ottawa , Ontario , Canada )
  • Hansom, Simon  ( University of Ottawa Heart Institute , Ottawa , Ontario , Canada )
  • Sadek, Mouhannad  ( Southlake Regional Health Centre , North York , Ontario , Canada )
  • Author Disclosures:
    Yuchen Dai: DO NOT have relevant financial relationships | George Wells: DO have relevant financial relationships ; Researcher:University of Ottawa Heart Institute:Active (exists now) | Rob Beanlands: DO have relevant financial relationships ; Research Funding (PI or named investigator):GEHC:Past (completed) ; Research Funding (PI or named investigator):LMI:Active (exists now) ; Advisor:JDI:Active (exists now) ; Advisor:GEHC:Active (exists now) ; Research Funding (PI or named investigator):MedTrace:Active (exists now) ; Research Funding (PI or named investigator):JDI:Active (exists now) | David Birnie: DO NOT have relevant financial relationships | Robert deKemp: DO have relevant financial relationships ; Royalties/Patent Beneficiary:Jubilant Radiopharma:Active (exists now) ; Research Funding (PI or named investigator):Siemens Molecular Imaging:Active (exists now) | Pablo Nery: DO NOT have relevant financial relationships | Anahita Tavoosi: DO NOT have relevant financial relationships | Girish Nair: DO have relevant financial relationships ; Research Funding (PI or named investigator):Johnson and Johnson:Active (exists now) ; Consultant:johnson and johnson:Active (exists now) ; Speaker:Johnson and Johnson:Active (exists now) ; Research Funding (PI or named investigator):Johnson and Johnson:Active (exists now) ; Research Funding (PI or named investigator):Abbott :Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Calum Redpath: No Answer | Mehrdad Golian: No Answer | Rebecca Thornhill: DO NOT have relevant financial relationships | Elena Pena-Fernandez: DO NOT have relevant financial relationships | Simon Hansom: DO NOT have relevant financial relationships | Mouhannad Sadek: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:
More abstracts on this topic:
Catheter ablation approach and outcome in HIV+ patients with atrial fibrillation: a systematic review and meta-analysis

Mazetto Roberto, Bastos Eduarda, Guida Camila, Bulhões Elísio Bulhões, Queiroz Ivo, Antunes Vanio, Defante Maria Luiza Rodrigues, Romeiro Pedro, Barbosa Lucas, X. Mendes Beatriz, Silva Catarina

Catheter Ablation Versus Antiarrhythmic Drugs as First Line Therapy for Ventricular Tachycardia:
A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sabina Michael, Ibrahim Mohamed, Khanani Aqeel, Trube Jennifer, Massaro Joseph, Gharacholou Shahyar, Fernandez Joel

More abstracts from these authors:
The Need for Ongoing Oral Anticoagulation in Patients with Clinical Stroke Risk Factors After Successful Catheter Ablation of Atrial Fibrillation: The OCEAN Randomized Trial

Verma Atul, Essebag Vidal, Champagne Jean, Hill Michael, Smith Eric, Wells George, Birnie David, Jiang Chenyang, Heidbuchel Hein, Hindricks Gerhard, Kirchhof Paulus, Healey Jeff, Sharma Mike, Ha Andrew

Cardiac Magnetic Resonance Imaging vs Positron Emission Tomography in the Assessment of Viability in Ischemic Cardiomyopathy. The Alternative Imaging Modalities in Heart Failure (AIM-HF) Clinical Trial

Tavoosi Anahita, Garrard Linda, Kandolin Riina, Guo Ann, Dekemp Robert, Wells George, Beanlands Rob, Mielniczuk Lisa, Paterson David, Omeara Eileen, White James, Larose Eric, Knuuti Juhani, Wiefels Christiane, Chow Benjamin, Chen Li

You have to be authorized to contact abstract author. Please, Login
Not Available